Ditchcarbon
  • Contact
  1. Organizations
  2. Unipharm, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Unipharm, Inc. Sustainability Profile

Company website

Unipharm, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across various regions. Founded in 1995, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded medications. Unipharm's core offerings include a diverse range of pharmaceutical products, with a focus on injectables, oral solids, and topical formulations. What sets Unipharm apart is its commitment to innovation and quality, ensuring that all products meet stringent regulatory standards. With a strong market position, Unipharm has achieved significant milestones, including numerous FDA approvals and partnerships that enhance its product portfolio. The company continues to strive for excellence, making it a trusted name in the healthcare sector.

DitchCarbon Score

How does Unipharm, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Unipharm, Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

28%

Let us know if this data was useful to you

Unipharm, Inc.'s reported carbon emissions

Unipharm, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Unipharm may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, Unipharm's future climate commitments will be crucial for aligning with global standards and expectations.

How Carbon Intensive is Unipharm, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Unipharm, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Unipharm, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Unipharm, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Unipharm, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Unipharm, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Unipharm, Inc.'s Emissions with Industry Peers

Vitabiotics Ltd.

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 7 hours ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251209.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy